DUTCH Test Interpretation by Decade of Life

What the DUTCH Test Actually Measures

The DUTCH test does not report serum hormone levels. It quantifies the urinary metabolites of those hormones, giving a downstream picture of how the body is actually processing what it produces. That distinction matters clinically.

A woman can show a normal serum estradiol and still have a DUTCH that reveals preferential conversion down the 16-alpha-hydroxyestrone pathway, a pattern some researchers associate with higher estrogen-sensitive tissue exposure. Conversely, a man can show borderline-low serum testosterone but demonstrate strong androgen metabolite output, suggesting adequate tissue activation.

The Core Marker Categories

Estrogens. The panel reports estrone (E1), estradiol (E2), and estriol (E3), plus their Phase I hydroxylation metabolites: 2-hydroxyestrone (2-OHE1), 4-hydroxyestrone (4-OHE1), and 16-alpha-hydroxyestrone (16-OHE1). The 2:16 ratio and the 4-OHE1 fraction are the two numbers most practitioners focus on when assessing estrogen detoxification.

Androgens. DHEA-S, testosterone, and DHT are reported indirectly via their metabolites: androsterone, etiocholanolone, and 5-alpha/5-beta reduced androgen fractions. These metabolites give a better picture of androgen availability at the tissue level than a single serum testosterone snapshot.

Progesterone. Pregnanediol is the primary urinary proxy. In cycling women, a mid-luteal pregnanediol below roughly 1,500 mcg/g creatinine suggests inadequate corpus luteum output, even if serum progesterone appears acceptable.

Cortisol and the HPA Axis. Free cortisol and free cortisone appear at four time points (waking, 30 min post-wake, afternoon, bedtime), allowing reconstruction of the diurnal curve and the cortisol awakening response (CAR). Total cortisol metabolites (THF + THE + allo-THF) reflect overall cortisol production rather than just free output. Cortisol physiology and its diurnal secretion pattern are reviewed extensively in the NIH endocrinology literature.

Melatonin and Organic Acids. The extended DUTCH Complete also quantifies 6-OHMS (melatonin metabolite), B12 markers, oxidative stress markers (8-OHdG), and neurotransmitter metabolites. These add context, especially in patients presenting with sleep disruption or mood concerns.

Why Metabolites Beat a Single Serum Draw

A single morning serum estradiol captures one moment in a pulsatile system. Urinary metabolites over a full day average the output across hours, smooth out pulsatility, and add information about enzymatic activity (CYP1B1, COMT, 5-alpha reductase) that serum panels cannot provide. A 2019 analysis in the Journal of Applied Laboratory Medicine confirmed that dried urine collection produces results with intra-assay CV below 5% for most sex hormone metabolites. (Source)

How to Read DUTCH Results in Your 20s

Women in their 20s are at or near peak reproductive hormone output. The clinical job in this decade is establishing a personal baseline and identifying early dysfunction, not treating age-related decline.

Estrogen Metabolites in the 20s

Estradiol metabolite output is highest in this decade. A healthy 2:16 OHE1 ratio sits between 2.0 and 4.0. The 4-OHE1 fraction should remain below 0.15 relative to total estrogens. Elevated 4-OHE1 in a 20-something without exogenous hormone exposure warrants investigation of CYP1B1 polymorphisms and dietary estrogen load.

Mid-luteal pregnanediol in a normally cycling 20-year-old typically ranges from 1,500 to 5,000 mcg/g creatinine. Values consistently below 1,200 suggest luteal phase deficiency, a condition documented in approximately 5% of women with regular cycles but relevant to roughly 25-35% of women with subfertility. One NIH-cited review places luteal-phase progesterone insufficiency as a contributing factor in a significant proportion of early pregnancy losses.

Cortisol and DHEA in the 20s

The cortisol awakening response is typically the most strong in this decade. A healthy CAR shows a 50-160% rise from waking to 30-minute cortisol. DHEA-S peaks between ages 20 and 25 and should show high-normal androgen metabolite output (androsterone plus etiocholanolone combined often above 3,000 mcg/g creatinine in women, above 6,000 in men).

Blunted CAR in a 20-something is a meaningful signal. A 2018 paper in Psychoneuroendocrinology (N=669) found that individuals with CAR amplitude below 2.5 nmol/L reported significantly higher rates of burnout symptoms, even after adjusting for sleep duration. (Source)

DUTCH Interpretation in the 30s

The 30s mark the beginning of what endocrinologists call the "perimenopause precursor" zone for women and the start of measurable androgen decline for men. Neither is dramatic, but both are detectable on DUTCH.

Progesterone Decline Begins

Ovulatory frequency starts to decrease subtly after age 32. As a result, mid-luteal pregnanediol values that once reached 4,000+ mcg/g creatinine may drop toward the 1,500-2,500 range even in healthy, regularly cycling women. This decline matters because progesterone's neuroprotective and anti-anxiety properties are dose-dependent. Research published in Endocrinology confirms progesterone's role as a neurosteroid with GABA-A receptor modulation via its allopregnanolone metabolite.

Androgen Metabolites in Men in Their 30s

Men typically see a 1% per year fall in testosterone starting around age 30, per the Massachusetts Male Aging Study. (Source) On a DUTCH panel, this appears as a slow reduction in androsterone and etiocholanolone. Total androgen metabolites above 5,000 mcg/g creatinine remain reasonable for a 35-year-old man. Values below 3,500 mcg/g creatinine in this age group deserve clinical attention, especially if the patient reports fatigue, reduced libido, or body composition changes.

Cortisol Load Creeps Up

The 30s often coincide with peak occupational and domestic stress. Total cortisol metabolites (THF + THE + allo-THF) can begin to rise above the population median. A value persistently above 4,500 mcg/g creatinine combined with a flat diurnal curve (minimal difference between morning and bedtime free cortisol) suggests HPA dysregulation rather than appropriate stress response.

DUTCH Interpretation in the 40s

The 40s are the decade of highest diagnostic yield from DUTCH testing, particularly for women. Perimenopause is not a single event; it is a 7-10 year hormonal transition that typically begins in the early-to-mid 40s for most women. The Study of Women's Health Across the Nation (SWAN) documented that the menopausal transition begins on average at age 47.5, with FSH rising and estradiol variability increasing well before the final menstrual period.

Estrogen Variability and the DUTCH Panel

In perimenopause, estrogen metabolite output becomes erratic. A single DUTCH run in this decade may show high-normal E2 metabolites one cycle and low-normal the next. Practitioners should ideally run two DUTCH panels six months apart before making treatment decisions in a 42-48-year-old woman.

The 2:16 OHE1 ratio can shift unfavorably in this decade. Estrogen total output falls, but the proportion going down the 16-alpha pathway does not always fall proportionally. An acceptable 2:16 ratio in the 40s is still above 2.0, with the same 2.0-4.0 target range applying across all reproductive and post-reproductive years.

Progesterone Collapse

Pregnanediol drops precipitously for many women in their 40s, often falling below 800 mcg/g creatinine in the mid-luteal phase. This progesterone-estrogen imbalance, sometimes called estrogen dominance in functional medicine literature (though the more accurate term is relative progesterone insufficiency), drives many of the classic perimenopausal symptoms: heavy periods, breast tenderness, and disrupted sleep. Bioidentical progesterone supplementation dosed to raise pregnanediol above 1,200 mcg/g creatinine is a common clinical target in this decade.

Male Androgen Decline Becomes Clinically Visible

Men in their 40s with total androgen metabolites below 3,000 mcg/g creatinine and a 5-alpha to 5-beta ratio below 0.8 may be showing early signs of androgen insufficiency. DHT metabolite fractions (5-alpha androstanediol glucuronide proxies) below the lower quartile for this age group are associated in some research with reduced lean mass and increased visceral adiposity.

DUTCH Interpretation in the 50s

Menopause (defined as 12 consecutive months without a period) occurs at a median age of 51.4 years in U.S. Women, per the SWAN data. (Source) Post-menopausal DUTCH interpretation uses different reference intervals, and collection timing is no longer cycle-dependent.

Post-Menopausal Estrogen Targets

In a woman not on hormone therapy, post-menopausal E2 metabolite output is very low. Estrone (E1) becomes the dominant estrogen, produced primarily by aromatization in adipose tissue. A post-menopausal woman's DUTCH may show E1 metabolites in the 200-600 mcg/g creatinine range while E2 metabolites fall below 100 mcg/g creatinine.

For women on systemic estradiol therapy, the Menopause Society (formerly NAMS) recommends the lowest effective dose. (The Menopause Society 2022 Hormone Therapy Position Statement) On DUTCH, most practitioners target E2 metabolites in the 200-600 mcg/g creatinine range for women on standard doses of transdermal estradiol (0.05-0.1 mg/day), with the 2:16 ratio maintained above 2.0 regardless of therapy status.

Cortisol Flattening in the 50s

Total cortisol output continues a slow decline after menopause, but the diurnal curve often flattens further. A healthy 54-year-old on no medications should still show morning free cortisol at least twice the bedtime value. A flat pattern (less than 1.5x difference) warrants evaluation for HPA hypo-reactivity, which some researchers associate with increased fatigue and inflammatory tone. Research from the NIH shows that blunted cortisol reactivity in midlife women is associated with elevated inflammatory cytokine levels.

The HealthRX clinical team uses a four-quadrant framework for post-menopausal DUTCH interpretation: (1) estrogen metabolite adequacy, (2) estrogen detoxification quality (2:16 ratio, 4-OHE1 fraction), (3) adrenal reserve (CAR amplitude, total cortisol metabolites), and (4) androgen floor (DHEA-S proxy via androgen metabolite sum). Each quadrant gets a red/yellow/green designation before a treatment recommendation is made. This prevents single-marker overinterpretation, which is the most common clinical error on DUTCH panels.

DUTCH Interpretation in the 60s and 70s

Hormone output at these decades is low and relatively stable. The clinical focus shifts from managing transition to supporting floor levels adequate for bone density, cognitive function, cardiovascular risk modulation, and muscle preservation.

Androgen Floors in Older Men

The Endocrine Society's 2018 Clinical Practice Guideline on male hypogonadism notes that testosterone deficiency should be diagnosed only when both low serum levels and consistent symptoms are present. (Source) On DUTCH, a 65-year-old man with total androgen metabolites below 2,000 mcg/g creatinine and symptomatic hypogonadism has a clear pattern supporting further clinical workup. The 5-alpha to 5-beta androgen metabolite ratio below 0.7 in this age group may also suggest reduced 5-alpha reductase activity, relevant for practitioners managing DHT-sensitive conditions.

Estrogen and Bone Health in Older Women

Even in the 70s, estrogen metabolite adequacy matters for skeletal health. A 2020 JAMA Internal Medicine analysis found that women over 65 on estrogen therapy showed significantly lower rates of hip fracture compared to age-matched non-users. (Source) On DUTCH, women in the 70s on low-dose estrogen therapy (typically 0.025 mg transdermal estradiol) often show E2 metabolites in the 80-200 mcg/g creatinine range. Maintaining the 2:16 ratio above 2.0 remains the target at this age.

DHEA and Adrenal Decline

DHEA-S falls roughly 1-2% per year throughout adulthood, reaching approximately 20-30% of peak values by the mid-70s. (Source) On DUTCH, DHEA metabolite output (androsterone + etiocholanolone in women) below 500 mcg/g creatinine in a 70-year-old woman is expected. Values that fall below 300 mcg/g creatinine, especially combined with a flat cortisol curve and low morning free cortisol (<6 nmol/L on the DUTCH scale), may warrant assessment for adrenal insufficiency with a formal cosyntropin stimulation test.

Estrogen Detoxification Ratios Across All Decades

The 2-OHE1 to 16-OHE1 ratio deserves its own section because it applies across all age groups and often trips up first-time DUTCH interpreters.

A 2008 prospective study published in Cancer Epidemiology, Biomarkers and Prevention (N=10,786) found that women with a urinary 2:16 OHE1 ratio below 1.0 had a statistically higher risk of estrogen-receptor-positive breast cancer over a 12-year follow-up, with a hazard ratio of 1.33 (95% CI 1.05-1.69, P<0.05). (Source) The study authors wrote: "Higher urinary 2:16 OHE1 ratios were associated with a statistically significant reduction in breast cancer risk among premenopausal women."

The 4-OHE1 fraction, though produced in smaller quantities, is considered by some researchers to be more genotoxic than 16-OHE1 due to its propensity for quinone formation. A 4-OHE1 value above 0.15 relative to total estrogens deserves attention at any decade. Dietary interventions that upregulate CYP1A1 over CYP1B1 (indole-3-carbinol, DIM supplementation, cruciferous vegetable intake) are first-line before any pharmaceutical approach.

Cortisol Awakening Response: The Single Most Actionable DUTCH Metric

The CAR is arguably the most clinically actionable single output from the DUTCH test at any age. It reflects HPA-axis reactivity to the transition from sleep to wakefulness and is distinct from the overall diurnal cortisol pattern.

Normal CAR Values by Decade

• Ages 20-39: Waking to 30-minute rise of 60-160%, absolute rise of 8-20 nmol/L (free cortisol units)
• Ages 40-59: Waking to 30-minute rise of 50-130%, absolute rise of 6-18 nmol/L
• Ages 60+: Waking to 30-minute rise of 40-110%, absolute rise of 4-14 nmol/L

These figures are consistent with population data reviewed in a 2016 systematic meta-analysis of CAR across 64 studies (N>12,000 participants). (Source)

What a Blunted CAR Means Clinically

A blunted CAR (rise <40% regardless of age decade) has been associated in prospective data with burnout, PTSD, chronic fatigue, and hypothyroidism. It is not a diagnosis on its own, but it functions as a triage signal. The clinical response depends on context: a 45-year-old perimenopausal woman with blunted CAR, flat diurnal cortisol, and low DHEA metabolites has a different workup path than a 28-year-old male athlete with the same CAR pattern.

A raised CAR (rise >200% or absolute morning cortisol >25 nmol/L on DUTCH free-cortisol units) paired with elevated total cortisol metabolites suggests hyperactivation, most commonly seen in early-stage HPA upregulation from chronic stress, subclinical hyperthyroidism, or exogenous glucocorticoid rebound.

Medication and Supplement Effects on DUTCH Results

Several commonly prescribed agents distort DUTCH results in ways that are not always flagged during result interpretation.

Oral estrogens (but not transdermal) significantly raise sex hormone-binding globulin and alter hepatic estrogen metabolism, producing dramatically different metabolite ratios compared to transdermal delivery at equivalent serum levels. The DUTCH test is not validated for women on oral contraceptives; Precision Analytical explicitly notes this limitation in their collection instructions.

Biotin supplementation above 5 mg/day can interfere with immunoassay-based lab tests, though the DUTCH platform uses LC-MS/MS, which is not affected by biotin interference the way RIA-based serum panels are.

Melatonin supplementation at doses above 1 mg taken within four hours of the bedtime collection will artificially raise the 6-OHMS marker. Patients should discontinue melatonin 48 hours before collection or document the dose clearly on the requisition form.

Patients taking exogenous DHEA supplementation should hold it 24-48 hours before collection, or results should be interpreted with the caveat that DHEA metabolite output reflects both endogenous and exogenous sources.

Ordering the DUTCH Test: Practical Protocol by Decade

Getting the right collection timing matters as much as interpretation.

Cycling women (any decade): Collect on days 19-22 of a 28-day cycle (day 1 = first day of period). This captures peak mid-luteal progesterone and allows comparison of estrogen and progesterone output in the same window.

Women in perimenopause with irregular cycles: Collect any day, then repeat the same day of the following cycle if a period occurs. Label both with actual cycle day.

Post-menopausal women and men: Collect on any morning. Consistency of collection time across repeat panels matters more than the specific day.

Athletes: Avoid collection in the 24 hours following maximal exertion. Cortisol and androgen metabolites can be transiently elevated by heavy training, producing a misleading single-day snapshot.

The Endocrine Society's 2014 guideline on endocrine testing notes that all hormone tests, urine or serum, require clinical context for interpretation and should not be used as standalone diagnostic tools. (Source)